OXAPEX
LIVE

Serial Number

90696150

Owner

First Gain International Limited

Attorney

Timothy T. Wang

Filing Date

May 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

OXAPEX Trademark

Serial Number: 90696150 • Registration: 6824225

OXAPEX is a trademark filed by First Gain International Limited on May 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

First Gain International Limited (10 trademarks)

Room 2301, 23F, Fu Fai Commercial Centre
Sheung Wan , HK

Entity Type: 16

Trademark Details

Filing Date

May 7, 2021

Registration Date

August 23, 2022

Published for Opposition

June 7, 2022

Goods & Services

Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; Biological preparations for medical and veterinary purposes, namely, Sterile Solutions for use in Oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; Biological preparations for medical and veterinary purposes, namely, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases

Medical services, namely, healthcare services in the nature of medical information, hospital services, medical assistance services, medical clinic services, and therapy services, physical therapy; Veterinary services in the nature of veterinary information; Hygienic and beauty care for human beings or animals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 3, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 29, 2022 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Apr 26, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 22, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 12, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 10, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2021 NWOS
NEW APPLICATION ENTERED
May 11, 2021 NWAP